Dynamic consent, rather than broad consent, is a relatively recent phenomenon, and one that has been given impetus by an Australian Genomics innovation featured in the latest edition of the European Journal of Human Genetics.
A new international database will help accelerate the establishment of a robust evidence base for gene-disease relationships and improve diagnostic outcomes of genomic testing.
A recent study has made a significant breakthrough in achieving national consistency in the interpretations of gene tests for hereditary cancer diagnosis.
Over the past five years, Australian Genomics has built a national network with the ability to adapt to new procedures and promote the move from a research setting to clinical operations.
Almost 800 people from 50 countries zoomed in to the first virtual conference of the Global Alliance for Genomics and Health on September 29 and 30. The GA4GH 8th Plenary Meeting was scheduled to be held in Melbourne this year, but due to COVID-19 was instead held online. And that, it seems, was an attractive alternative, with 1200 people registering for the event overall.
The successful implementation of genomic medicine will require greater global collaboration and communication across diverse communities with different policies and needs, say the authors of an editorial in Science Translational Medicine.